Hypertension with metabolic syndrome: think thiazides are old hat? ALLHAT says think again

Affiliations

Comment

Michael D Mendoza et al. J Fam Pract. 2008 May.

. 2008 May;57(5):306-10.

¹ Department of Family Medicine, The University of Chicago, USA. mdmendoz@uchicago.edu

Abstract

Outcomes support chlorthalidone despite its metabolic profile

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR. Wright JT Jr, et al. Arch Intern Med. 2008 Jan 28;168(2):207-17. doi: 10.1001/archinternmed.2007.66. Arch Intern Med. 2008. PMID: 18227370 Free PMC article. Clinical Trial.

1. Wright JT, Jr, Harris-Haywood S, Pressel S, et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2008; 168:207–217.. - PMC - PubMed
1. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427.. - PMC - PubMed
1. Eberly LE, Cohen JD, Prineas R, Yang L. Intervention Trial Research group. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the Multiple Risk Factor Intervention Trial experience. Diabetes Care. 2003; 26:848–854.. - PubMed
1. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hyper-tension. N Engl J Med. 1989; 321:868–873.. - PubMed
1. Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens. 2006;24:3–10.. - PubMed